Stock Movers Rheinmetall Up, Lufthansa Climbs, Zealand Pharma Plunges
Mar 6, 2026
Defense stocks climb amid rising geopolitical tensions, lifting names like Rheinmetall. An airline posts strong results and predicts much better earnings by 2026, sending its shares higher. A biotech company's experimental obesity treatment disappoints in trial results, triggering a sharp stock sell-off.
AI Snips
Chapters
Transcript
Episode notes
European Defence Stocks Rise On Middle East Tensions
- Defence stocks rally on expectations of increased military spending amid escalating Middle East conflict.
- Rheinmetall, Hensoldt and Rheinmetall peers climbed as markets priced in more orders and higher future earnings.
Lufthansa Sees Profit Upside And Route Opportunities
- Lufthansa reported strong results and said 2026 profit should be significantly above 2025, lifting airline sector sentiment.
- The carrier sees an opportunity to add long-haul flights to Asia and Africa as Middle Eastern hubs face disruption.
Zealand Pharma Stock Falls After Disappointing Obesity Data
- Zealand Pharma shares plunged after its obesity shot produced average weight loss below analyst benchmarks in a Roche-partnered study.
- The result undermines a $5 billion partnership's sales forecasts and raises doubts about competing with Eli Lilly and Novo Nordisk.